200 related articles for article (PubMed ID: 35322568)
1. Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry.
Gabrielle PH; Maitrias S; Nguyen V; Arnold JJ; Squirrell D; Arnould L; Sanchez-Monroy J; Viola F; O'Toole L; Barthelmes D; Creuzot-Garcher C; Gillies M;
Acta Ophthalmol; 2022 Dec; 100(8):e1569-e1578. PubMed ID: 35322568
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.
Daien V; Nguyen V; Essex RW; Morlet N; Barthelmes D; Gillies MC;
Ophthalmology; 2018 Jan; 125(1):66-74. PubMed ID: 28801117
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH; Nguyen V; Arnould L; Viola F; Zarranz-Ventura J; Barthelmes D; Creuzot-Garcher C; Gillies M;
Ophthalmol Retina; 2022 Nov; 6(11):1044-1053. PubMed ID: 35589075
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
Nguyen CL; Gillies MC; Nguyen V; Daien V; Cohn A; Banerjee G; Arnold J;
Ophthalmology; 2019 May; 126(5):735-742. PubMed ID: 30529685
[TBL] [Abstract][Full Text] [Related]
5. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy.
Matsunaga DR; Su D; Sioufi K; Obeid A; Wibbelsman T; Ho AC; Regillo CD
Ophthalmol Retina; 2021 Apr; 5(4):342-347. PubMed ID: 32763426
[TBL] [Abstract][Full Text] [Related]
6. Associations and Outcomes of Patients with Submacular Hemorrhage Secondary to Age-related Macular Degeneration in the IVAN Trial.
Mehta A; Steel DH; Muldrew A; Peto T; Reeves BC; Evans R; Chakravarthy U;
Am J Ophthalmol; 2022 Apr; 236():89-98. PubMed ID: 34626573
[TBL] [Abstract][Full Text] [Related]
7. Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration.
Cho SC; Cho J; Park KH; Woo SJ
Acta Ophthalmol; 2021 Aug; 99(5):e706-e714. PubMed ID: 33289345
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration.
Kim HS; Cho HJ; Yoo SG; Kim JH; Han JI; Lee TG; Kim JW
Eye (Lond); 2015 Sep; 29(9):1141-51. PubMed ID: 26272443
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
Jackson TL; Bunce C; Desai R; Hillenkamp J; Lee CN; Lois N; Peto T; Reeves BC; Steel DH; Edwards RT; van Meurs JC; Wafa H; Wang Y
Trials; 2022 Jan; 23(1):99. PubMed ID: 35101110
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor.
Prahs P; Brandl C; Helbig H; Volz C
Rom J Ophthalmol; 2023; 67(3):260-266. PubMed ID: 37876508
[No Abstract] [Full Text] [Related]
12. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
Bardak H; Bardak Y; Erçalık Y; Erdem B; Arslan G; Timlioglu S
Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
Treumer F; Roider J; Hillenkamp J
Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
[TBL] [Abstract][Full Text] [Related]
14. Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
Gillies MC; Nguyen V; Daien V; Arnold JJ; Morlet N; Barthelmes D
Ophthalmology; 2016 Dec; 123(12):2545-2553. PubMed ID: 27707549
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration.
Shin KH; Lee TG; Kim JH; Kim JW; Kim CG; Lee DW; Han JI; Lew YJ; Cho HJ
Korean J Ophthalmol; 2016 Oct; 30(5):369-376. PubMed ID: 27729757
[TBL] [Abstract][Full Text] [Related]
16. European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice: Data from the Fight Retinal Blindness! Registry.
Boudousq C; Nguyen V; Hunt A; Gillies M; Zarranz-Ventura J; O'Toole L; Mangelschots E; Kusenda P; Schmidt-Erfurdt U; Pollreisz A; Kheir WJ; Arruabarrena C; Vujosevic S; Barthelmes D; Creuzot-Garcher C; Gabrielle PH
Ophthalmol Retina; 2024 Jun; 8(6):527-536. PubMed ID: 38185453
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration.
Jain S; Kishore K; Sharma YR
Indian J Ophthalmol; 2013 Sep; 61(9):490-6. PubMed ID: 24104707
[TBL] [Abstract][Full Text] [Related]
18. Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration.
Arnold JJ; Campain A; Barthelmes D; Simpson JM; Guymer RH; Hunyor AP; McAllister IL; Essex RW; Morlet N; Gillies MC;
Ophthalmology; 2015 Jun; 122(6):1212-9. PubMed ID: 25846847
[TBL] [Abstract][Full Text] [Related]
19. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
[TBL] [Abstract][Full Text] [Related]
20. FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fight Retinal Blindness! Project.
Cornish EE; Teo KY; Nguyen V; Squirrel D; Young S; Gillies MC; Barthelmes D
Retina; 2021 Jan; 41(1):118-124. PubMed ID: 32310628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
